Interact to see
Advertisement
Advertisement
CSVAX vs TROZX
CSVAX vs TROZX Comparison
Open Charts CSVAX vs TROZX
CSVAX vs TROZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CSVAX vs. TROZX commentary
Aug 31, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSVAX is a Hold and TROZX is a StrongBuy.
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 17.2B vs. CSVAX (702M). TROZX pays higher dividends than CSVAX: TROZX (2.83) vs CSVAX (2.28). CSVAX was incepted earlier than TROZX: CSVAX (24 years) vs TROZX (6 years). CSVAX (1.28) is less costly to investors than TROZX (0.65). TROZX is a more actively managed with annual turnover of: 15.00 vs. CSVAX (13.00). TROZX has a lower initial minimum investment than CSVAX: TROZX (0) vs CSVAX (2000). TROZX (28.11) and CSVAX (27.09) have marching annual gain over last year. TROZX return over 5 years is better than : 105.02 vs. CSVAX (42.20).
| CSVAX | TROZX | CSVAX / TROZX | |
| Total Expense Ratio | 1.20 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.28 | 0.65 | 197% |
| Fund Existence | 24 years | 6 years | - |
| Gain YTD | 19.000 | 17.358 | 109% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 702M | 17.2B | 4% |
| Annual Yield % from dividends | 2.28 | 2.83 | 80% |
| Returns for 1 year | 27.09 | 28.11 | 96% |
| Returns for 3 years | 58.58 | 95.46 | 61% |
| Returns for 5 years | 42.20 | 105.02 | 40% |
| Returns for 10 years | 87.33 | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFBFX | 31.60 | -0.07 | -0.22% |
| Emerald Bkg & Finac Evolution - Inv | |||
| MUXAX | 31.18 | -0.08 | -0.26% |
| Victory S&P 500 Index A | |||
| JHURX | 51.42 | -0.61 | -1.17% |
| JPMorgan Emerging Markets Equity R3 | |||
| PCSMX | 18.20 | -0.45 | -2.41% |
| Principal SmallCap Growth I R6 | |||
| OASGX | 14.07 | -0.37 | -2.56% |
| Optimum Small-Mid Cap Growth A | |||